Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

OC-3 Inhibitors

Chemical classes of inhibitors are typically named based on the specific target they inhibit. An inhibitor class named OC-3 Inhibitors would suggest a collection of compounds designed to specifically inhibit the function of a protein named OC-3. These inhibitors would interact with the protein at specific sites, such as the active site, allosteric site, or other regulatory domains, to impede its function. The mechanism of inhibition could include competitive inhibition, where the compound competes with the natural substrate or ligand of the protein for binding; noncompetitive inhibition, where the inhibitor binds to a different site and changes the protein's shape, preventing it from functioning effectively; or irreversible inhibition, where the inhibitor forms a covalent bond with the protein, permanently disabling it.

The development of such inhibitors would likely involve a detailed understanding of the protein's structure and function, including the identification of key domains and residues critical for its activity. High-throughput screening, rational drug design, and computational modeling are common methods used in the discovery of inhibitors. Once potential compounds are identified, their inhibitory effects can be refined through iterative cycles of chemical modification and biological testing. The specificity and efficacy of inhibitors are paramount, as they must selectively target the protein of interest while minimizing off-target effects. Chemical modifications can also improve the pharmacokinetic properties of the inhibitors, ensuring that they are stable, bioavailable, and able to reach their target within the cell.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$153.00
$396.00
113
(4)

Inhibits a broad spectrum of protein kinases, potentially altering the phosphorylation status of the protein and related pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

Inhibits PI3K, leading to reduced AKT activation, which may affect proteins that are downstream of the PI3K/AKT pathway.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, which can disrupt downstream signaling pathways that may be crucial for the activity of the target protein.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Inhibits MEK, which is part of the MAPK/ERK pathway, possibly affecting the activity of proteins regulated by this pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

Inhibits p38 MAPK, potentially altering the activity of proteins that interact with or are regulated by p38 MAPK.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

Inhibits JNK, which can affect proteins that are regulated by the JNK signaling pathway.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Inhibits PI3K, potentially affecting signaling pathways that involve PI3K activity and its downstream effectors.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Inhibits the proteasome, potentially affecting the degradation pathway of the protein and thus its cellular levels.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Inhibits the proteasome, affecting protein degradation, which may alter the stability and function of the target protein.

KN-93

139298-40-1sc-202199
1 mg
$182.00
25
(1)

Inhibits CaMKII, potentially affecting calcium signaling pathways that may be important for the function of the target protein.